Position in BCRX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$7,215,040
-$1,572,462 QoQ
Shares Held
721,504
-21.8% QoQ
Ownership
0.282%
of shares outstanding
% of Portfolio
2.70%
of 13F equity value
Holder Rank
#54
of 318 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BCRX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Rosalind Advisors, Inc. holds $37,825,481 across 5 Drug Manufacturers - Specialty & Generic names. BCRX ranks #2 (19.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | XERS |
Xeris Biopharma Holdings, Inc.
|
2,908,981 | $23,039,129 | |
| 2 | BCRX |
Biocryst Pharmaceuticals Inc
This page
|
721,504 | $7,215,040 | |
| 3 | TLPH |
Talphera, Inc.
|
5,169,501 | $5,324,586 | |
| 4 | BFRI |
Biofrontera Inc.
|
1,275,609 | $1,206,726 | |
| 5 | AQST |
Aquestive Therapeutics, Inc.
|
250,000 | $1,040,000 |
All Filings in BCRX
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,215,040 | 721,504 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $8,787,502 | 923,057 | Shares | Sole | 2026-05-14 | |
| No filing history on record for this holder in this stock. | ||||||